Surrey Heartlands

Joint Formulary & PAD

Oxycodone with naloxone - Restless Leg Syndrome

You are here : Home > Formulary Search > Oxycodone with naloxone - Restless Leg Syndrome

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :

No records returned.

Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NFD2
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Oxycodone with naloxone
Indication :
Restless Leg Syndrome
Group Name :
Keywords :
Brand Names Include :
Targinact, Myloxifin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Oxycodone with naloxone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Restless Leg Syndrome.

Committee Recommendations (1)

22 Jan 18 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Prescribing Clinical Network does not recommend the use of oxycodone and naloxone combination product
Oxycodone and Naloxone Combination Product will be considered BLACK on the traffic light system, prescribers should:
o NOT initiate oxycodone and naloxone combination product for any new patient
AND
o De-prescribe oxycodone and naloxone combination product, with specialist support if appropriate, in all patients
In exceptional circumstances where there is a clinical need for oxycodone and naloxone combination product to be prescribed in primary care this should be undertaken in a cooperation arrangement with a multidisciplinary team and / or other healthcare professional